Ramsay Générale de Santé SA (GDS.PA)
EUR 9.66
(-0.21%)
EUR 9.66
(-0.21%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.49 EUR | -208.89% |
| 2022 | 0.45 EUR | -57.94% |
| 2021 | 1.07 EUR | 81.36% |
| 2020 | 0.59 EUR | 247.06% |
| 2019 | 0.17 EUR | -5.56% |
| 2018 | 0.18 EUR | 87.3% |
| 2017 | 0.10 EUR | -86.27% |
| 2016 | 0.70 EUR | 55.56% |
| 2015 | 0.45 EUR | 40.63% |
| 2014 | 0.32 EUR | -82.51% |
| 2013 | 1.83 EUR | 98.91% |
| 2012 | 0.92 EUR | 295.74% |
| 2011 | -0.47 EUR | -181.03% |
| 2010 | 0.58 EUR | -18.31% |
| 2009 | 0.71 EUR | -52.03% |
| 2008 | 1.48 EUR | 89.74% |
| 2007 | 0.78 EUR | -81.43% |
| 2006 | 4.20 EUR | 332.99% |
| 2005 | 0.97 EUR | 49.23% |
| 2004 | 0.65 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q1 | -0.08 EUR | -260.64% |
| 2023 Q3 | -0.03 EUR | 80.25% |
| 2023 FY | - EUR | -208.89% |
| 2023 Q4 | -0.29 EUR | -817.72% |
| 2023 Q2 | -0.16 EUR | -100.0% |
| 2022 Q2 | 0.40 EUR | 100.0% |
| 2022 FY | - EUR | -57.94% |
| 2022 Q4 | 0.05 EUR | 100.0% |
| 2022 Q3 | 0.02 EUR | -93.78% |
| 2022 Q1 | 0.20 EUR | -62.26% |
| 2021 Q4 | 0.53 EUR | 96.3% |
| 2021 FY | - EUR | 81.36% |
| 2021 Q1 | 0.27 EUR | 68.75% |
| 2021 Q2 | 0.54 EUR | 100.0% |
| 2021 Q3 | 0.27 EUR | -50.0% |
| 2020 Q4 | 0.16 EUR | 100.0% |
| 2020 FY | - EUR | 247.06% |
| 2020 Q3 | 0.08 EUR | -81.4% |
| 2020 Q2 | 0.43 EUR | 104.76% |
| 2020 Q1 | 0.21 EUR | 75.0% |
| 2019 Q1 | 0.01 EUR | -94.43% |
| 2019 Q2 | 0.02 EUR | 192.59% |
| 2019 Q3 | 0.06 EUR | 279.75% |
| 2019 Q4 | 0.12 EUR | 100.0% |
| 2019 FY | - EUR | -5.56% |
| 2018 FY | - EUR | 87.3% |
| 2018 Q4 | 0.10 EUR | 120.45% |
| 2018 Q3 | 0.04 EUR | 566.67% |
| 2018 Q2 | 0.01 EUR | 0.0% |
| 2018 Q1 | 0.01 EUR | -96.53% |
| 2017 Q4 | 0.19 EUR | 0.0% |
| 2017 Q3 | 0.19 EUR | 226.67% |
| 2017 Q1 | -0.15 EUR | -168.18% |
| 2017 Q2 | -0.15 EUR | 0.0% |
| 2017 FY | - EUR | -86.27% |
| 2016 Q3 | 0.22 EUR | 37.5% |
| 2016 Q2 | 0.16 EUR | 0.0% |
| 2016 FY | - EUR | 55.56% |
| 2016 Q1 | 0.16 EUR | 6.67% |
| 2016 Q4 | 0.22 EUR | 0.0% |
| 2015 Q1 | 0.10 EUR | 0.0% |
| 2015 FY | - EUR | 40.63% |
| 2015 Q2 | 0.10 EUR | 0.0% |
| 2015 Q3 | 0.15 EUR | 57.89% |
| 2015 Q4 | 0.15 EUR | 0.0% |
| 2014 FY | - EUR | -82.51% |
| 2014 Q2 | -0.19 EUR | -309.48% |
| 2014 Q1 | -0.05 EUR | -155.57% |
| 2013 Q3 | 0.37 EUR | -83.77% |
| 2013 Q1 | 0.02 EUR | -84.5% |
| 2013 Q2 | 2.28 EUR | 12158.06% |
| 2013 FY | - EUR | 98.91% |
| 2013 Q4 | 0.08 EUR | -77.43% |
| 2012 FY | - EUR | 295.74% |
| 2012 Q4 | 0.12 EUR | -62.5% |
| 2012 Q3 | 0.32 EUR | 52.38% |
| 2012 Q2 | 0.21 EUR | -12.5% |
| 2012 Q1 | 0.24 EUR | 71.43% |
| 2011 Q3 | 0.32 EUR | 149.23% |
| 2011 Q4 | 0.14 EUR | -56.25% |
| 2011 Q2 | -0.65 EUR | -261.11% |
| 2011 FY | - EUR | -181.03% |
| 2011 Q1 | -0.18 EUR | 64.71% |
| 2010 FY | - EUR | -18.31% |
| 2010 Q1 | -0.29 EUR | -131.87% |
| 2010 Q2 | -0.16 EUR | 44.83% |
| 2010 Q3 | 0.12 EUR | 175.0% |
| 2010 Q4 | -0.51 EUR | -525.0% |
| 2009 Q2 | 0.47 EUR | 0.0% |
| 2009 FY | - EUR | -52.03% |
| 2009 Q4 | 0.91 EUR | 19.74% |
| 2009 Q3 | 0.76 EUR | 61.7% |
| 2008 FY | - EUR | 89.74% |
| 2007 FY | - EUR | -81.43% |
| 2006 FY | - EUR | 332.99% |
| 2005 FY | - EUR | 49.23% |
| 2004 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Clariane SE | -0.86 EUR | 43.023% |
| LNA Santé SA | 2.29 EUR | 121.397% |